Advances in multiple sclerosis

Por: Hauser, Stephen L [Autor]Tipo de material: TextoTextoIdioma: Inglés Descripción: páginas: 54-68Tema(s): ALERGIA | INMUNOLOGÍA GENERAL | ENFERMEDAD AUTOINMUNE | MEDICINA CLINICA GENERAL | ENFERMEDAD INFLAMATORIA | ESCLEROSIS MULTIPLE | GENETICA | REUMATOLOGÍA | NEUROLOGÍA | NEUROCIRUGÍA | OFTALMOLOGÍA En: The New England Journal of MedicineResumen: Multiple sclerosis is a chronic autoimmune disorder that affects the central nervous system, causing episodes of neurologic dysfunction and often gradual disease progression. The immune system primarily targets myelin, the protective covering of nerve fibers, leading to inflammation and damage, and secondary neurodegeneration is a major cause of long-term disability. Common symptoms include vision problems, sensory disturbances, muscle weakness, balance difficulties, and bladder dysfunction. Important advances in treatment have improved outcomes in patients with relapsing forms of multiple sclerosis, particularly through highly effective immune-modifying therapies such as CD20-targeting monoclonal antibodies. However, treatment options for progressive forms remain limited, which highlights the need for therapies that can prevent progression and promote myelin repair. Comprehensive symptom management and lifestyle support are also essential to maintaining quality of life and reducing disability.
Etiquetas de esta biblioteca: No hay etiquetas de esta biblioteca para este título. Ingresar para agregar etiquetas.
    Valoración media: 0.0 (0 votos)
Tipo de ítem Ubicación actual Colección Signatura Info Vol Estado Fecha de vencimiento Código de barras
Títulos de Revistas Títulos de Revistas Biblioteca Central ESSALUD
Colección General NEJM (Navegar estantería) Vol.395, No.1 (2026) Disponible NEJM001

Multiple sclerosis is a chronic autoimmune disorder that affects the central nervous system, causing episodes of neurologic dysfunction and often gradual disease progression. The immune system primarily targets myelin, the protective covering of nerve fibers, leading to inflammation and damage, and secondary neurodegeneration is a major cause of long-term disability. Common symptoms include vision problems, sensory disturbances, muscle weakness, balance difficulties, and bladder dysfunction. Important advances in treatment have improved outcomes in patients with relapsing forms of multiple sclerosis, particularly through highly effective immune-modifying therapies such as CD20-targeting monoclonal antibodies. However, treatment options for progressive forms remain limited, which highlights the need for therapies that can prevent progression and promote myelin repair. Comprehensive symptom management and lifestyle support are also essential to maintaining quality of life and reducing disability.